Al-Hajj et al, enriched a CD44+/CD24−/low cell population from human breast cancer that displayed cancer stem/progenitor cell properties and was capable of forming tumors in immuno-compromised mice with higher efficiency than cells with alternative phenotypes [1]. The gene discussed is CD44; the disease is breast carcinoma.